Heart Failure 2026

Name: Heart Failure 2026
Start: 2026-05-09
End: 2026-05-12
Location: Barcelona, Spain

The congress brings together healthcare professionals, researchers, and industry experts to discuss advances in heart failure diagnosis, treatment, and patient management.

9 - 12 May, 2026

Barcelona, Spain

About Heart Failure 2026 Congress

The Heart Failure Congress, organized by the Heart Failure Association of the ESC, is one of the leading scientific meetings dedicated to heart failure research and clinical practice.

Roche Diagnostics will participate in Heart Failure 2026 through a sponsored symposium and its presence at Exhibition Booth B230. Contributions to the scientific program include one moderated poster and one sponsored symposium, bringing together experts to discuss developments in heart failure diagnostics and patient management.

We look forward to welcoming you at the Roche booth and engaging with the heart failure community during Heart Failure 2026 in Barcelona.

Agenda

Moderated poster

Refining early post-discharge management in acute heart failure using an international delphi consensus

This session will present the results of an international Delphi consensus exploring early post-discharge management in patients hospitalised for acute heart failure. Experts will discuss practical strategies for rapid optimisation of guideline-directed medical therapy, the role of biomarker-guided follow-up, and implementation challenges across diverse real-world patient profiles. The discussion aims to provide clinicians with pragmatic frameworks to improve treatment uptake and patient outcomes after discharge.

Date: 11 May 2026 Time: 12:30 - 13:15
Room: Moderated ePoster 4 - Research Gateway

Symposium

Innovative pathways to accelerate heart failure identification in the community

The symposium will focus on the importance of early diagnosis and management of heart failure. Cardiologists and primary care specialists will discuss diagnostic tools (including POC) and strategies that enable identification of patients at high risk of heart failure in the community as well as accelerated pathways for prompt investigations in symptomatic patients. The audience will learn about different approaches implemented in different countries and new upcoming data.

Strategies for early identification and management of HF - Prof. Antoni Bayes-Genis
Leveraging diagnostic tools for accelerated HF diagnosis in primary care - Prof. Clare Taylor
Has the role of biomarkers for early HF detection changed in the digital era? - Dr. Ambarish Pandey

Date: 11 May 2026 Time: 14:30 - 15:15
Room: Room 2